U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07639944) titled 'An Open Label Study Assessing REN Treatment in Headache Management in Temporomandibular Disorders' on May 26.
Brief Summary: Temporomandibular disorders (TMD) encompass a group of conditions involving the masticatory muscles, temporomandibular joint (TMJ), and associated structures. TMD is the most common cause of non-odontogenic orofacial pain and is the second most commonly occurring musculoskeletal condition. Up to 70% of the general population experiences signs and/or symptoms of TMD, with headache presenting as one of the most common manifestations. Recent studies highlight the comorbid presence of headache and TMD, hypothesizi...